Challenges in oral drug delivery of antiretrovirals and the innovative strategies to overcome them
- 1 August 2016
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 103, 105-120
Abstract
No abstract availableKeywords
Funding Information
- European Union's—Seventh Framework Program (612675-MC-NANOTAR)
- Phyllis and Joseph Gurwin Fund for Scientific Advancement (2020855)
This publication has 170 references indexed in Scilit:
- Long-acting injectable antiretrovirals for HIV treatment and preventionCurrent Opinion in HIV and AIDS, 2013
- Efavirenz Dissolution Enhancement I: Co-MicronizationPharmaceutics, 2012
- Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriersAdvanced Drug Delivery Reviews, 2012
- Polymeric Conjugates for Drug DeliveryChemistry of Materials, 2012
- Unique Risks, Benefits, and Challenges of Developing Drug-Drug Combination Products in a Pharmaceutical Industrial SettingCombination Products in Therapy, 2012
- Substrate-Dependent Breast Cancer Resistance Protein (Bcrp1/Abcg2)-Mediated Interactions: Consideration of Multiple Binding Sites in in Vitro Assay DesignDrug Metabolism and Disposition, 2009
- Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissuesAdvanced Drug Delivery Reviews, 2009
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticlesJournal of Controlled Release, 2008
- Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulationsInternational Journal of Pharmaceutics, 2008
- Tumor pH-responsive flower-like micelles of poly(l-lactic acid)-b-poly(ethylene glycol)-b-poly(l-histidine)Journal of Controlled Release, 2007